Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Century Therapeutics (IPSC) Return on Invested Capital (2022 - 2024)

Century Therapeutics (IPSC) has disclosed Return on Invested Capital for 3 consecutive years, with 0.78% as the latest value for Q4 2024.

  • On a quarterly basis, Return on Invested Capital fell 4.0% to 0.78% in Q4 2024 year-over-year; TTM through Dec 2024 was 0.78%, a 4.0% decrease, with the full-year FY2024 number at 0.8%, down 20.0% from a year prior.
  • Return on Invested Capital was 0.78% for Q4 2024 at Century Therapeutics, down from 0.69% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.42% in Q4 2022 to a low of 0.81% in Q1 2024.
  • A 3-year average of 0.63% and a median of 0.69% in 2024 define the central range for Return on Invested Capital.
  • Biggest YoY gain for Return on Invested Capital was -4bps in 2024; the steepest drop was -37bps in 2024.
  • Century Therapeutics' Return on Invested Capital stood at 0.42% in 2022, then crashed by -77bps to 0.74% in 2023, then fell by -6bps to 0.78% in 2024.
  • Per Business Quant, the three most recent readings for IPSC's Return on Invested Capital are 0.78% (Q4 2024), 0.69% (Q3 2024), and 0.73% (Q2 2024).